Report of the American Diabetes Association.docx
- 文档编号:26448514
- 上传时间:2023-06-19
- 格式:DOCX
- 页数:71
- 大小:46.20KB
Report of the American Diabetes Association.docx
《Report of the American Diabetes Association.docx》由会员分享,可在线阅读,更多相关《Report of the American Diabetes Association.docx(71页珍藏版)》请在冰豆网上搜索。
ReportoftheAmericanDiabetesAssociation
ReportoftheAmericanDiabetesAssociation'sTaskForceonStandardizationoftheInsulinAssay
Robbins,DavidC.(chair);Andersen,Lennart;Bowsher,Ron;Chance,Ron;Dinesen,Bo;Frank,Bruce;Gingerich,Ron;Goldstein,David;Widemeyer,Hsaio-Mei;Haffner,Steven;Hales,C.Nick;Jarett,Leonard;Polonsky,Kenneth;Porte,Daniel;Skyler,Jay;Webb,George;Gallagher,Kathy
AuthorInformation
FromtheNovoNordiskLaboratories(L.Andersen),NovoNordiskA/S,Bagsvaerd.
andtheStenoDiabetesCenter(B.Dinesen),Gentofte,Denmark
TheLillyResearchLaboratories(R.Bowsher,R.Chance,B.Frank),EliLilly,Indianapolis,Indiana
TheDepartmentofPediatrics(D.Goldstein,H.-M.Widemeyer),UniversityofMissouri,Columbia
andLincoResearch(R.Gingerich),St.Louis,Missouri
TheUniversityofTexasHealthSciencesCenter(S.Haffner),SanAntonio,Texas
CambridgeUniversity(C.N.Hales),Cambridge,U.K.
TheDepartmentofPathology(L.Jarett),UniversityofPennsylvania,Philadelphia,Pennsylvania
TheDepartmentofMedicine(K.Polonsky),UniversityofChicagoHospitalandClinics,Chicago,Illinois
TheDepartmentofMedicine(D.Porte),UniversityofWashington,Seattle,Washington
TheDepartmentofMedicine(J.Skyler),UniversityofMiami,Miami,Florida
andthePennMedicalLaboratory(D.C.Robbins,G.Webb,K.Gallagher),MedlanticResearchInstitute,Washington,DC.
AddresscorrespondenceandreprintrequeststoDr.DavidC.Robbins,MedlanticResearchInstitute,108IrvingSt.NW,Washington,DC20010.
BacktoTop
Abstract
Recentlarge-scaleepidemiologicalstudiesdemonstratethatbloodconcentrationsofimmunoreactiveinsulinpredictthedevelopmentofNIDDMandIDDMandareassociatedwiththeriskofseveraldegenerativediseases,suchascoronaryandperipheralvesselatherosclerosis,hypertension,anddyslipidemia.Thereliabilityofthesemeasurementsisdependentonabiologicalassaythathasnotbeenwellstandardizedbetweenlaboratories.Recognizingthis,theAmericanDiabetesAssociationorganizedataskforcetoassesscomparabilityofbloodinsulinmeasurementsbetweenlaboratoriesandtosuggesttechniquestoimprovecomparability.Thetaskforcefoundthatidenticalserumandplasmasamplesmeasuredindifferentlaboratoriesproducedwidelydisparatevaluesthatwereunacceptableforpopulationcomparisons.Useofasinglereferencestandarddidlittletoimprovecomparability.Assaycharacteristicssuchaslinearity,recovery,accuracy,andcross-reactivitytoproinsulinanditsprimaryconversionintermediatesvariedamongthelaboratories,andtheydidnotreadilyexplaindifferencesinthemeasurementsmadefromassaytoassay.Useofthesameassaykitindifferentlaboratoriesdidnotalwaysensurecomparablemeasurements.Linearregressionofassayresultsfromonelaboratorytoanarbitrarilychosenreferenceassaygreatlyimprovedcomparabilityanddemonstratedthepotentialvalueincomparingeachassaytoareferencemethod.Thetaskforcereportdefinesacceptableassaycharacteristicsandproposesathree-stepprocessofinsulinassayproficiencyandcomparability.Acentralreferenceassayandongoingsampleexchangewillbeneededtoallowreliablecomparisonsofinsulinmeasurementsmadeindifferentlaboratories.Rigorousqualitycontrolandcontinuousqualityimprovementareneededtomaintainreliabilityoftheinsulinmeasurement.Diabetes45:
242-256,1996
ADA,AmericanDiabetesAssociation;CV,coefficientofvariation;ELISA,enzyme-linkedimmunosorbentassay;IRMA,immunoradiometricassay;LOD,limitofdetection;LOQ,limitofquantitation;RIA,radioimmunoassay;WHO,WorldHealthOrganization.
Theinsulinassayhasbeenusedforover30yearstoestimatetheconcentrationofinsulin-relatedmoleculesinplasmaandotherbiologicalfluids[1].Initially,thedevelopmentoftheassayfocusedontheeaseofperformanceandthereproducibilityofmethodinasinglelaboratory.Becauseofimmunochemicaldifferencesbetweenbovine,porcine,andhumaninsulin,themixedbovine-porcine-bioassayedpreparationsusedasbiologicalstandardsthatwereavailableatthetimewerenotsuitableforstandardizingthehumaninsulintobeassayed.Therefore,whileimpurehumaninsulinwasavailableforuseasanin-housestandard,eachlaboratorywasresponsibleforitsowncalibrationandqualitycontrolandnointerlaboratorycomparisonwaspossible.Sincetheapplicationoftheassaywaslargelyrelatedtothestudyofthepathophysiologyofdiabetesandrelateddisordersinsmallnumbersofsubjectsortotheunderstandingofthephysiologicalregulationofinsulinsecretioninanimalsorinvitro,therewasperceivedtobealimitedneedforstandardizationbetweenlaboratories.Nevertheless,sincetherewasoftengreatvarianceinreportedvaluesfromdifferentlaboratoriesaroundtheworld,attemptsweremadetoprovideforinterlaboratorycomparisonsusingthevariousmethodologiesavailablefromtimetotime[2-4].Whilelimited,thesestudiesdemonstratedaratherlargevariation.Inpart,thismayhavebeenduetothelackofacommonstandardofdefinedcontent.Recognizingthisneed,theWorldHealthOrganization(WHO)providedaninternationallyrecognizedpreparationforeachspeciesofpurifiedinsulin--bovine,porcine,andhuman--thatcouldbeusedforanexternalstandard[5].TheavailabilityoflargequantitiesofpurehumaninsulinthroughrecombinantDNAtechnologyintheensuingyearsfurtherenhancedthepossibilityofsuchstandardization.Furthermore,thistechnologymeansthatapurechemicalfortheassayisnowavailablethatdoesnotdependonbioassay.Thepotencyoftherecombinantpurenativeinsulinmaterialswas6.0nmol/Uin1991[6](thoughasrecentlyas1993itwasnecessaryforcommentstobepublishedtoclarifythebiopotencyofpurehumaninsulin[7]).Thistranslatesto28.7U/mgpureinsulin.
Nevertheless,theuseoftheassayinclinicalmedicinehaslargelybeenconfinedtothediagnosisofinsulinoma.Therefore,whileitmightbepossibleandevendesirabletostandardizetheassay,therehasnotbeenaconcertedeffortbyanyorganizationtodososeriously.Large-scaleepidemiologicalstudiesdemonstratethatbloodconcentrationsofimmunoreactiveinsulin(thetermimmunoreactiveinsulinisusedinreferencetoassaysthatmayrecognizeothersubstances,inadditiontoinsulin,thatshareantigenicepitopeswithinsulin,suchasproinsulin,proinsulinconversionintermediates,andinsulinderivativesproducedbydeterioration,glycosylation,dimerization,degradation,etc.)predictthedevelopmentofNIDDM[8-10],andthereistheincreasingpossibilitythatimmunoreactiveinsulinlevelsmaybeusedintheclinicalassessmentofpatientstopredictdiabetessusceptibility[9,11,12].
However,thereliabilityoftheseclinicalandepidemiologicalconclusionsisdependentonthecharacteristicsoftheassays.Itisreported,forexample,thatproinsulinisdisproportionatelyelevatedinNIDDM[13,14]andtheabsolutelevelof"true"or"specific"insulinmayactuallybelowinNIDDM[15].Thus,aninsulinassaythatcross-reactswithproinsulinanditsdegradationproductsmaycontributetodifferentconclusionsthanonethatisinsulinspecific.Thecirculatingamountsofproinsulinmayalsobeelevatedamongindividualswithimpairedglucosetolerance[16].Furthermore,atleasttworeportsfindthatelevatedproinsulin(butnotspecificinsulin)predictsthedevelopmentofNIDDM[17,18].Hyperinsulinemiaand/orinsulinresistanceisalsoassociatedwithcoronaryheartdiseaseandcardiovascularriskfactors[19,20].Withsomeimmunoassays,proinsulinismorecloselyassociatedwithriskfactorsthanisinsulininbothdiabetic[21]andnondiabeticsubjects[22].
Inordertoresolvethisproblem,theAmericanDiabetesAssociation(ADA)appointedataskforcetoexplorethepotentialofstandardizingtheinsulinassay.Theworkofthetaskforceproceededinthreephases:
anassessmentofthestateoftheart,thedevelopmentofastandardizedprotocol,andanassessmentofitsapplicabilityinasmallgroupofexperiencedlaboratories.Fromthisexperience,aprotocolforstandardizationhasbeendeveloped.
BacktoTop
RESULTS
Participatinglaboratoriesandtheassayusedinthestandardizationprogram.LaboratoriesinvitedtoparticipateintheADAinsulinassaystandardizationprogramwerechosenonthebasisoftheirinterestinlaboratorymedicineappliedtodiabetesorbecauseoftheirparticipationinstudiesinwhichinsulinhasbeenacentraloutcomemeasure.ThetypesofassaysusedaresummarizedinTable1.Noteespeciallythatthreeoftheassayswereenzyme-linkedimmunosorbentassays(ELISAs)(laboratoriesC,E,andG).AllthreeELISAsandtworadioimmunoassays(RIAs)werereportedtobeinsulinspecific.Oneinsulinassay(laboratoryD)wasknowntocross-reactnearlyequallywithproinsulin,proinsulinconversionintermediates,andinsulin.Theremainderoftheinsulinassayswereknowntocross-reactwithproinsulinanditsconversionintermediatestovariousdegrees.ThispointisillustratedinTable4andisaddressedmorefullybelow.
Table1
Table4
Unknownsampleexchangetodetermineinterlaboratoryvariance.Comparabilitybetweenlaboratorieswasunknown.Tomeasurevariabilitybetweenlaboratoriesandprecisionwithinlaboratories,thetaskforceobtainedbloodfrom16volunteers.Ofthese,14werehealthydonorswhotooknoroutinemedicationsanddidnothavediabetes.Onedonor(identifiedasdonor11inFigure1)hadatypeIVhyperlipidemiaandobesity,anddonor4hadIDDMandlowtitersofanti-insulinantibodies.Bloodwaswithdrawninasingledona
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- Report of the American Diabetes Association
![提示](https://static.bdocx.com/images/bang_tan.gif)